Amyotrophic Lateral Sclerosis

Key Points

• Amyotrophic lateral sclerosis is a progressive neurologic disorder of motor neurons.
• Motor neuron degeneration causes progressive weakness, fasciculation, and muscle atrophy.
• Onset is usually in older adulthood (commonly after about age 60), and about 5-10% of cases are inherited.
• Voluntary functions such as walking, speaking, chewing, and breathing decline over time.
• Cognitive-behavioral changes can occur in selected cases, including frontotemporal-neurocognitive overlap.
• Disease-modifying and symptom-management medications may slow decline, but no cure exists and survival is often limited to years after diagnosis.
• Nutrition support is a core survival lever: energy deficit and calorie restriction can worsen outcomes, while adequate high-calorie intake may slow decline in some cohorts.

Pathophysiology

ALS is characterized by progressive degeneration and death of motor neurons, causing loss of neural signaling to skeletal muscle. As denervation progresses, affected muscles weaken, twitch, and atrophy, leading to cumulative loss of voluntary movement.

Progressive respiratory-muscle involvement increases risk of respiratory failure. Bulbar involvement can impair chewing and swallowing, increasing aspiration and nutrition risk.

Most ALS cases are sporadic with unclear etiology. Reported risk associations include tobacco exposure and selected toxin exposures, while a smaller subset is familial.

Classification

• Limb-onset pattern: Progressive extremity weakness and functional decline.
• Bulbar-onset pattern: Early speech/swallow impairment with escalating airway and nutrition risk.

Nursing Assessment

NCLEX Focus

Prioritize respiratory status and swallowing safety as weakness progresses.

• Assess progressive pattern of motor weakness and ADL loss.
• Assess early symptom cluster including limb fasciculation, cramping, spasticity, slurred speech, and dysphagia.
• Assess for speech/swallow changes and aspiration indicators.
• Assess respiratory effort, secretion clearance, and fatigue burden.
• Assess for late-stage progression cues such as drooling, severe dysarthria/anarthria, emotional lability, and unintended weight loss.
• Assess for cognitive and behavioral changes, including executive dysfunction and frontotemporal-overlap features.
• Assess psychosocial stress in patients and caregivers as independence declines.

Diagnostic and Monitoring Data

• Diagnosis is primarily clinical and exclusion-based; blood/urine testing may support differential workup and can show elevated neurofilament light-chain patterns in neuronal injury contexts.
• Use combined nerve-conduction and EMG testing to identify motor-neuron and denervation abnormalities.
• MRI may reveal corticospinal changes and helps rule out structural mimics (for example spinal tumor or compressive pathology).
• Lumbar puncture, nerve biopsy, and muscle biopsy are often used to exclude alternative diagnoses rather than confirm ALS directly.

Nursing Interventions

• Support airway and secretion management as respiratory muscles weaken.
• Give breathing support escalation when indicated, including noninvasive or invasive mechanical ventilation pathways.
• Coordinate nutrition and swallow safety strategies for bulbar dysfunction.
• Avoid unintentional calorie restriction; monitor weight trend closely and escalate early for higher-calorie texture-adapted planning when intake drops.
• Cluster care and assistive planning to preserve functional energy.
• Encourage healthy foods and textures that are easier to swallow as bulbar weakness progresses.
• Assist with prescribed stretching and mobility-equipment use to preserve independence as long as possible.
• Coordinate interdisciplinary support for mobility, communication, and caregiver burden.
• Coordinate speech, physical, and occupational therapy for communication support, range-of-motion maintenance, and adaptive-device training.
• Integrate mental-health and palliative-care planning early as prognosis and symptom burden progress.
• Provide ongoing emotional support to clients and families coping with progressive decline.

Progressive Respiratory Decline

Worsening respiratory-muscle weakness can rapidly become life-threatening and requires timely escalation.

Pharmacology

Drug Class	Examples	Key Nursing Considerations
ALS disease-modifying therapy	Riluzole, edaravone, sodium phenylbutyrate-taurursodiol contexts	May slow decline in selected patients; monitor adherence, GI or dizziness effects, bruising/headache patterns, and function trends.
Symptom-management agents	Individualized by symptom profile	Therapy is supportive and should be reassessed as function changes.

Clinical Judgment Application

Clinical Scenario

A patient with ALS reports worsening fatigue, weak cough, and difficulty finishing meals.

• Recognize Cues: Progressive respiratory and bulbar weakness.
• Analyze Cues: Airway protection and nutrition safety are becoming immediate priorities.
• Prioritize Hypotheses: Risk of aspiration and respiratory deterioration is high.
• Generate Solutions: Escalate respiratory and swallow assessment with interdisciplinary planning.
• Take Action: Implement airway-focused care and adapt feeding/energy-conservation strategies.
• Evaluate Outcomes: Breathing and intake remain stable with reduced complication risk.

Related Concepts

• nursing-care-priorities-for-neuromuscular-impairment - Shared respiratory, mobility, and skin-integrity priorities.
• collaborative-and-environmental-neuromuscular-care - Interdisciplinary and caregiver-support planning.
• dysphagia - Swallowing dysfunction and aspiration-risk management.

Self-Check

1. Why can severe motor disability occur while cognition remains relatively preserved in ALS?
2. Which cue indicates highest immediate escalation priority in advanced ALS?
3. What interdisciplinary referrals best support bulbar and respiratory decline?